Astellas Pharma Net Income 2012-2026 | ALPMY

Astellas Pharma annual/quarterly net income history and growth rate from 2012 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Astellas Pharma net income for the quarter ending June 30, 2026 was $0.894B, a 367.68% increase year-over-year.
Astellas Pharma net income for the twelve months ending June 30, 2026 was $1.848B, a 25.58% increase year-over-year.
Astellas Pharma annual net income for 2026 was $1.924B, a 469.27% increase from 2025.
Astellas Pharma annual net income for 2025 was $0.338B, a 199.12% increase from 2024.
Astellas Pharma annual net income for 2024 was $0.113B, a 84.77% decline from 2023.

Astellas Pharma Annual Net Income (Millions of US $)
2026	$1,924
2025	$338
2024	$113
2023	$742
2022	$1,017
2021	$1,086
2020	$1,793
2019	$2,002
2018	$1,554
2017	$1,953
2016	$1,608
2015	$1,236
2014	$882
2013	$881
2012	$954

Astellas Pharma Quarterly Net Income (Millions of US $)
2026-06-30	$894
2025-06-30	$472
2024-06-30	$241
2023-06-30	$242
2022-06-30	$191
2021-06-30	$279
2020-06-30	$469
2019-06-30	$533
2018-06-30	$502
2017-06-30	$382
2016-09-30	$475
2016-06-30	$620
2016-03-31	$259
2015-12-31	$505
2015-09-30	$478
2015-06-30	$366
2015-03-31	$163
2014-12-31	$394
2014-09-30	$327
2014-06-30	$351
2013-06-30	$223
2012-06-30	$444

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$26.892B	$14.211B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$68.396B	22.59
Takeda Pharmaceutical (TAK)	Japan	$59.919B	11.13
UCB SA (UCBJY)	Belgium	$45.739B	0.00
Otsuka Holdings, - (OTSKY)	Japan	$39.680B	14.84
BeOne Medicines - (ONC)	Switzerland	$38.041B	61.00
Sandoz Group AG (SDZNY)	Switzerland	$35.464B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$34.072B	21.27
Zoetis (ZTS)	United States	$30.343B	11.16
United Therapeutics (UTHR)	United States	$21.460B	17.90
Merck (MKKGY)	Germany	$19.487B	15.54
Shionogi (SGIOY)	Japan	$15.947B	9.37
IPSEN (IPSEY)	France	$15.395B	0.00
Neurocrine Biosciences (NBIX)	United States	$15.249B	20.72
Summit Therapeutics (SMMT)	United States	$13.881B	0.00
Orion OYJ (ORINY)	Finland	$12.984B	18.93
Madrigal Pharmaceuticals (MDGL)	United States	$12.089B	0.00
Corcept Therapeutics (CORT)	United States	$11.979B	263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$11.965B	15.26
Crinetics Pharmaceuticals (CRNX)	United States	$9.013B	0.00
Eisai (ESAIY)		$8.924B	0.00
Ionis Pharmaceuticals (IONS)	United States	$7.852B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.049B	13.27
Stevanato Group S.p.A (STVN)	Italy	$6.523B	32.64
Centessa Pharmaceuticals (CNTA)	United Kingdom	$6.267B	0.00
Oruka Therapeutics (ORKA)	United States	$6.105B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$5.317B	19.36
Grifols, S.A (GRFS)	Spain	$5.009B	0.00
Definium Therapeutics (DFTX)	United States	$4.947B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.923B	0.00
Relay Therapeutics (RLAY)	United States	$4.157B	0.00
Indivior Pharmaceuticals (INDV)	United States	$4.039B	9.38
Enliven Therapeutics (ELVN)	United States	$3.910B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.855B	11.93
Amylyx Pharmaceuticals (AMLX)	United States	$3.694B	0.00
Dyne Therapeutics (DYN)	United States	$3.343B	0.00
Hypermarcas (HYPMY)	Brazil	$3.203B	9.10
Soleno Therapeutics (SLNO)	United States	$2.717B	228.83
NewAmsterdam Pharma (NAMS)	Netherlands	$2.529B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.390B	45.28
Nektar Therapeutics (NKTR)	United States	$2.275B	0.00
Ocular Therapeutix (OCUL)	United States	$2.238B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.146B	15.81
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$2.085B	5.63
Xencor (XNCR)	United States	$1.766B	0.00
KARDIGAN INC (KARD)	United States	$1.735B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.366B	107.00
Harrow (HROW)	United States	$1.269B	0.00
Seaport Therapeutics (SPTX)	United States	$1.229B	0.00
Aktis Oncology (AKTS)	United States	$1.204B	0.00
Cronos Group (CRON)	Canada	$1.179B	29.09
Bioventus (BVS)	United States	$1.093B	17.10
Savara (SVRA)	United States	$1.081B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.993B	0.00
Cybin (HELP)	Canada	$0.992B	0.00
Theravance Biopharma (TBPH)	United States	$0.885B	0.00
Avalo Therapeutics (AVTX)	United States	$0.862B	0.00
Ardelyx (ARDX)	United States	$0.847B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.821B	11.32
Esperion Therapeutics (ESPR)	United States	$0.819B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.773B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.753B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.753B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.750B	0.00
Apnimed (APMD)		$0.711B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.711B	3.13
Zevra Therapeutics (ZVRA)	United States	$0.692B	7.37
Ironwood Pharmaceuticals (IRWD)	United States	$0.671B	5.21
OmniAb (OABI)	United States	$0.630B	0.00
Altimmune (ALT)	United States	$0.628B	0.00
Aquestive Therapeutics (AQST)	United States	$0.604B	0.00
Evotec AG (EVO)	Germany	$0.580B	0.00
ProKidney (PROK)	United States	$0.526B	0.00
Indaptus Therapeutics (INDP)	United States	$0.485B	0.00
Relmada Therapeutics (RLMD)	United States	$0.474B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.423B	0.00
Larimar Therapeutics (LRMR)	United States	$0.406B	0.00
Prelude Therapeutics (PRLD)	United States	$0.361B	0.00
Century Therapeutics (IPSC)	United States	$0.359B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.339B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.322B	0.00
Avita Medical (RCEL)	United States	$0.314B	0.00
Pyxis Oncology (PYXS)	United States	$0.278B	0.00
USANA Health Sciences (USNA)	United States	$0.275B	15.05
Elite Pharmaceuticals (ELTP)	United States	$0.268B	12.44
Lyell Immunopharma (LYEL)	United States	$0.267B	0.00
Akebia Therapeutics (AKBA)	United States	$0.250B	0.00
Galectin Therapeutics (GALT)	United States	$0.246B	0.00
Nature's Sunshine Products (NATR)	United States	$0.230B	11.17
AleAnna (ANNA)	United States	$0.226B	17.84
Protara Therapeutics (TARA)	United States	$0.222B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.215B	0.00
Siga Technologies (SIGA)	United States	$0.214B	0.00
Journey Medical (DERM)	United States	$0.208B	0.00
Profound Medical (PROF)	Canada	$0.208B	0.00
Korro Bio (KRRO)	United States	$0.207B	0.00
Surrozen (SRZN)	United States	$0.206B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.199B	0.00
Organogenesis (ORGO)	United States	$0.188B	0.00
Minerva Neurosciences (NERV)	United States	$0.183B	0.00
MediWound (MDWD)	Israel	$0.173B	0.00
Atrium Therapeutics (RNA)	United States	$0.173B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.147B	0.00
Innate Pharma SA (IPHYF)	France	$0.138B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.131B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.129B	0.00
VAXART, INC (VXRT)	United States	$0.117B	3.00
Assertio Holdings (ASRT)	United States	$0.116B	0.00
Rafael Holdings (RFL)	United States	$0.111B	0.00
Vivani Medical (VANI)	United States	$0.111B	0.00
Allergy Therapeutics (AGYTF)	United Kingdom	$0.103B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.099B	0.00
PolyPid (PYPD)	Israel	$0.098B	0.00
HST Global (HSTC)	United States	$0.092B	0.00
ElectroCore (ECOR)	United States	$0.091B	0.00
Fractyl Health (GUTS)	United States	$0.090B	0.00
Nutriband (NTRB)	United States	$0.083B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.083B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.080B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.079B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.078B	0.00
Gain Therapeutics (GANX)	United States	$0.075B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.073B	0.00
Champions Oncology (CSBR)	United States	$0.066B	0.00
Talphera (TLPH)	United States	$0.062B	0.00
Nuo Therapeutics (AURX)		$0.061B	0.00
Heron Therapeutics (HRTX)	United States	$0.060B	0.00
Dominari Holdings (DOMH)	United States	$0.053B	0.00
Veraxa Biotech AG (VRXA)	United States	$0.048B	0.00
SCYNEXIS (SCYX)	United States	$0.044B	0.00
Incannex Healthcare (IXHL)	Australia	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Lite Strategy (LITS)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.035B	0.00
Context Therapeutics (CNTX)	United States	$0.033B	0.00
Optimi Health (OPTH)	Canada	$0.029B	0.00
Cosmos Health (COSM)	United States	$0.028B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.027B	0.00
Plus Therapeutics (PSTV)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.025B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.022B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Lipocine (LPCN)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.016B	0.00
Enlivex (ENLV)	Israel	$0.015B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.015B	0.00
BioVie (BIVI)	United States	$0.015B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Vyome Holdings (HIND)	United States	$0.014B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.014B	0.00
Scienture Holdings (SCNX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
Natural Alternatives (NAII)	United States	$0.012B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
Xenetic Biosciences (XBIO)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.009B	0.00
Wellgistics Health (WGRX)	United States	$0.009B	0.00
Traws Pharma (TRAW)	United States	$0.008B	0.00
Inotiv (NOTV)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.007B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.007B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.006B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.005B	0.00
Liminatus Pharma (LIMN)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
Niki BioSolutions (NIKI)	United Kingdom	$0.004B	0.00
Nuvilex (PMCB)	United States	$0.004B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.004B	0.00
Galmed Pharmaceuticals (EOCN)	Israel	$0.004B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.004B	0.00
Redhill Biopharma (RDHL)	Israel	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.003B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.003B	0.00
SciSparc (SPRC)	Israel	$0.003B	0.00
Vivos Therapeutics (VVOS)	United States	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.001B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.001B	0.00
Clearmind Medicine (CMND)	Canada	$0.001B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
CDT Equity (CDT)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00